CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 30607-30888 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T146","span":{"begin":0,"end":281},"obj":"Sentence"}],"text":"Thus, during the past three decades, a major focus of research has been on developing novel, highly attenuated, recombinant VACV strains (rVACV) that demonstrate significantly improved safety profiles and can be used in humans as potential vaccines candidates (83, 84) (Table 1) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T146","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, during the past three decades, a major focus of research has been on developing novel, highly attenuated, recombinant VACV strains (rVACV) that demonstrate significantly improved safety profiles and can be used in humans as potential vaccines candidates (83, 84) (Table 1) ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T73","span":{"begin":0,"end":281},"obj":"Epistemic_statement"}],"text":"Thus, during the past three decades, a major focus of research has been on developing novel, highly attenuated, recombinant VACV strains (rVACV) that demonstrate significantly improved safety profiles and can be used in humans as potential vaccines candidates (83, 84) (Table 1) ."}